Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
02/07/2008 | US20080032340 Peptide motifs for binding avidin or neutravidin |
02/07/2008 | US20080032318 Fret protease assays for clostridial toxins |
02/07/2008 | US20080031954 Modulation of angiogenesis by a-beta peptide fragments |
02/07/2008 | US20080031888 Tumor antigens |
02/07/2008 | US20080031812 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates, thereof, compositions and methods of synthesis and use |
02/07/2008 | DE102006035899A1 New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample |
02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
02/06/2008 | EP1884775A1 Method for diagnosis of a disease involving an anti-AT1-receptor antibody |
02/06/2008 | EP1884520A2 Daptomycin analogs as antibacterial agents |
02/06/2008 | CN101120014A Modulation of ovulation |
02/06/2008 | CN101120012A Metabolites of cyclosporin analogs |
02/06/2008 | CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds |
02/06/2008 | CN100366633C Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy |
02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
02/05/2008 | US7326686 Compounds and methods for regulating cell adhesion |
02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
02/05/2008 | US7326684 Peptides for enhancing resistance to microbial infections |
02/05/2008 | US7326682 Conotoxin peptides |
02/05/2008 | US7326566 Compositions and methods for screening antimicrobials |
02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
02/05/2008 | CA2218161C Peptide compositions with growth factor-like activity |
02/05/2008 | CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof |
02/05/2008 | CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
02/05/2008 | CA2136339C Derivatives of dolastatin |
02/05/2008 | CA2124953C Peptides related to prion proteins |
01/31/2008 | WO2008012102A2 Radiodense conjugate |
01/31/2008 | WO2008012086A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
01/31/2008 | WO2007122488A3 Radiofluorinated compounds and their preparation |
01/31/2008 | WO2007096855A3 Angiotensin-i-converting enzyme inhibitory |
01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
01/31/2008 | US20080027006 Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity |
01/31/2008 | US20080027003 Peptides Useful for Treating Gnrh Associated Diseases |
01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
01/31/2008 | US20080026990 18-Membered Nitrobenzyl- and Aminobenzyl-Substituted Cyclohexadepsipeptides for Controlling Endoparasites and a Process for Their Preparation |
01/31/2008 | US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF |
01/31/2008 | US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit |
01/31/2008 | DE102006035577A1 Röntgendichtes Konjugat Radiopaque conjugate |
01/31/2008 | CA2659225A1 Immunogenic compounds and protein mimics |
01/31/2008 | CA2595158A1 Polysaccharide-peptide conjugates for use as thrombin substrates |
01/30/2008 | EP1399471B1 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
01/30/2008 | CN101113164A 12 peptide specifically combined with tumor metastasis related protein PRL-3 and uses thereof |
01/30/2008 | CN101113163A Hla-a24-restricted cancer antigen peptides |
01/30/2008 | CN100365016C Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
01/30/2008 | CN100365015C 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
01/30/2008 | CN100365014C Tumor targeting agents and uses thereof |
01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
01/29/2008 | US7323542 Bioactive amino acid sequences conjugated with biocompatible, biodegradable delivery system for use in treatment and prevention of bone disorders: prosthetics |
01/29/2008 | US7323444 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
01/29/2008 | CA2471775C Targeted cytotoxic anthracycline analogs |
01/29/2008 | CA2295321C Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
01/29/2008 | CA2237721C Antineoplastic peptides |
01/24/2008 | WO2008010098A2 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
01/24/2008 | WO2008010010A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
01/24/2008 | WO2008009895A2 Matriptase-2 |
01/24/2008 | WO2008009672A1 Process for the manufacture of peptides |
01/24/2008 | WO2008009085A1 Anti-inflammatory and antiallergic cyclic peptides |
01/24/2008 | WO2007072063A3 A bioassay and peptides for use therein |
01/24/2008 | WO2007021661A3 Ligands of sh3 domains |
01/24/2008 | WO2004081188A3 Non-toxic membrane-translocating peptides |
01/24/2008 | US20080021199 Methods for the specific preparation of lysobactin fragments |
01/24/2008 | US20080021198 Modulators of protein phosphatase 2A and PP2A methyl esterase |
01/24/2008 | US20080021197 reacting an acetyl cyclosporin aldehyde with an organozirconium reagent (Cp2Zr(H)Cl) to provide acetyl cyclosporin diene (the acetate of trans ISATX247) and deacetylating the acetyl cyclosporin diene to produce the trans-isomer of ISATX247; immunosuppressant |
01/24/2008 | US20080020979 Peptides of Syndecan-1 For Inhibiting Angiogenesis |
01/24/2008 | US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
01/24/2008 | US20080020377 Peptide-Based Method for Monitorting Gene Expression in a Host Cell |
01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
01/24/2008 | US20080019992 Antigen mimotopes and vaccine against cancerous diseases |
01/24/2008 | US20080019913 Enkepahlin analogs with improved bioavailability |
01/24/2008 | CA2657338A1 Anti-inflammatory and antiallergic cyclic peptides |
01/24/2008 | CA2656883A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
01/23/2008 | EP1881008A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
01/23/2008 | EP1881006A1 Parathyroid hormone analogues for the treatment of osteoporosis |
01/23/2008 | EP1881003A1 Compound having amino acid residue or peptide residue and process for producing the same |
01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
01/23/2008 | EP1880007A2 Personal care compositions and methods for their use |
01/23/2008 | EP1879911A1 Dye conjugates of template-fixed peptidomimetics |
01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
01/23/2008 | CN101111513A Glycopeptide antibiotic monomer derivative |
01/23/2008 | CN101111510A On-resin peptide cyclization |
01/23/2008 | CN101111258A Emulsified composition for dilution and cancer vaccine composition |
01/23/2008 | CN101111257A Methods of increasing cerebral blood flow |
01/23/2008 | CN101108875A Growth hormone releasing peptides |
01/23/2008 | CN100363383C Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use |
01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
01/22/2008 | CA2380569C Chimeric polypeptides, method for production and uses thereof |
01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
01/17/2008 | WO2007134127A3 Agents for imaging apoptosis |
01/17/2008 | WO2007064759A3 Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain |
01/17/2008 | WO2007035474A3 Transdermal delivery peptides and method of use thereof |
01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
01/17/2008 | US20080015164 Methods and compositions for inactivation of dihydrofolate reductase |
01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
01/17/2008 | US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
01/17/2008 | US20080014209 Peptide mimics of conserved Gonococcal epitopes and methods and compositions using them |
01/17/2008 | US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein |
01/17/2008 | CA2657665A1 Method and compositions for treating stroke with fever |